Dr. Eddrice McMullan praises Accuro for increasing first-attempt success rates and reducing needle passes and placement times, especially in patients with high BMI or scoliosis. “It’s genius,” she says, emphasizing its effectiveness when traditional methods fall short.
Recent Posts
- RIVANNA nominated for MedTech Scale-Up of the Year at MedTech World Awards 2026 | North America
- RIVANNA’s Accuro XV Demonstrates Feasibility of Musculoskeletal Imaging by Non-physician Users With Minimal Training
- RIVANNA expands multi-site clinical study for Accuro XV musculoskeletal imaging system
- Neuraxial Anesthesia: What is State of the Art in 2026?
- The Future of Neuraxial Anesthesia
